Your search returned 3 results.

Results
	1.	Lack of drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and warfarin in healthy volunteers. [electronic resource] by Macha, S Rose, P Mattheus, M Pinnetti, S Woerle, H J Producer: 20130930 In: Diabetes, obesity & metabolism vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment. [electronic resource] by Macha, S Mattheus, M Halabi, A Pinnetti, S Woerle, H J Broedl, U C Producer: 20141117 In: Diabetes, obesity & metabolism vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment. [electronic resource] by Macha, S Rose, P Mattheus, M Cinca, R Pinnetti, S Broedl, U C Woerle, H J Producer: 20150512 In: Diabetes, obesity & metabolism vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search